Investigators: Biosimilar Pegfilgrastim Has Advantages Over Wearable Injector

December 01, 2020

The wearable injector has a failure rate that adds hospitalization costs; therefore, biosimilar pegfilgrastim may hold cost advantages, investigators conclude.

Celltrion Relies on Domestic Construction Amid the Pandemic
Biosimilar Legal Roundup: November 2020
Newly Created Viatris Joins the Biosimilars Forum
Poll: How Much Do You Know About Biosimilar Suffixes?

Biosimilars Forum Chooses Director With Democratic Influence

November 23, 2020

Tony Hagen

Article

Meaghan Rose Smith's appointment comes during a time of challenges for the biologics industry.

European Commission Approves Pfizer's Pegfilgrastim Biosimilar

November 23, 2020

Tony Hagen

Article

Pfizer aims to begin marketing Nyvepria in the European Union in the first quarter of 2021.

The Top 5 Articles from ACR Convergence 2020

November 22, 2020

Video

Here are the top 5 biosimilar articles from the American College of Rheumatology (ACR) Convergence 2020.

Opinion: Embrace the Era of Next-Generation Biologics

November 21, 2020

Bincy P. Abraham, MD

Article

Bincy P. Abraham, MD, explains that even when payers allow coverage for biosimilars, providers may still be hesitant to use them.

Survey: Providers, Admins Struggle to Appreciate Biosimilar Suffixes

November 20, 2020

Tony Hagen

Article

The FDA naming convention and its utility are not well understood, and “poor” biosimilar knowledge may be partly to blame, investigators report.

Alvotech Files for US and EU Approval of Adalimumab Biosimilar

November 20, 2020

Tony Hagen

Article

The rheumatology and gastroenterology biosimilar candidate would enter the lucrative market established by Humira.

Samsung Biologics and AstraZeneca Dissolve Rituximab Partnership

November 20, 2020

Tony Hagen

Article

Their rituximab biosimilar candidate was advancing in clinical trials for equivalence but represented a business conflict.

The Top 5 Biosimilar Articles for the Week of November 16

November 20, 2020

Video

Here are the top 5 biosimilar articles for the week of November 16, 2020.

Fed Expert Describes Improving Regulatory, Policy Structure for Biosimilars

November 19, 2020

Tony Hagen

Article

Prior to the turmoil of the pandemic, the FDA and CMS were at work on shoring up the biosimilars market, and this work continues on various fronts, a regulatory/policy expert explains.

Celltrion to Break Ground on Massive New Biopharmaceutical Plant

November 19, 2020

Tony Hagen

Article

Plans for a $453.3 million high volume plant and research center were unveiled during an industry forum this week in Republic of Korea.

x